fda warning letter glp-1 solution september 9 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of GLP-1 RA prescription trends: January

2 If HbA 1c values exceed 9%, patients usually require a combination of two oral agents or they may be started on insulin directly

Because these prescriptions are designed for long-term use, patients who use semaglutide for weight loss may gain some or all their weight back if they stop taking the medication

However, some GI side effects still occur and the adherence requirement (empty stomach, etc.) requires patient education

Youll lose even more if you follow a balanced diet and increase your physical activity

Short-Term Use : In the short term, GLP-1 medications are effective in rapidly improving glycemic control and promoting weight loss